Registered number
12317218
AH PHARMS LTD
Filleted Accounts
30 September 2024
AH PHARMS LTD
Registered number: 12317218
Balance Sheet
as at 30 September 2024
Notes 2024 2023
£ £
Fixed assets
Tangible assets 3 1,759 2,058
Current assets
Cash at bank and in hand 31,224 66,566
Creditors: amounts falling due within one year 4 (20,480) (30,712)
Net current assets 10,744 35,854
Total assets less current liabilities 12,503 37,912
Creditors: amounts falling due after more than one year 5 (486) (2,592)
Net assets 12,017 35,320
Capital and reserves
Called up share capital 100 100
Profit and loss account 11,917 35,220
Shareholder's funds 12,017 35,320
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
ATIA HUSSAIN
Director
Approved by the board on 22 October 2024
AH PHARMS LTD
Notes to the Accounts
for the year ended 30 September 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 1 1
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 October 2023 2,992
At 30 September 2024 2,992
Depreciation
At 1 October 2023 934
Charge for the year 299
At 30 September 2024 1,233
Net book value
At 30 September 2024 1,759
At 30 September 2023 2,058
4 Creditors: amounts falling due within one year 2024 2023
£ £
Taxation and social security costs - 4,208
Other creditors 20,480 26,504
20,480 30,712
5 Creditors: amounts falling due after one year 2024 2023
£ £
Other creditors 486 2,592
6 Other information
AH PHARMS LTD is a private company limited by shares and incorporated in England. Its registered office is:
20 FITZROY ROAD
BRADFORD
BD3 9PD
AH PHARMS LTD 12317218 false 2023-10-01 2024-09-30 2024-09-30 VT Final Accounts July 2024 ATIA HUSSAIN No description of principal activity 12317218 2022-10-01 2023-09-30 12317218 core:WithinOneYear 2023-09-30 12317218 core:AfterOneYear 2023-09-30 12317218 core:ShareCapital 2023-09-30 12317218 core:RetainedEarningsAccumulatedLosses 2023-09-30 12317218 2023-10-01 2024-09-30 12317218 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 12317218 bus:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 12317218 bus:Director40 2023-10-01 2024-09-30 12317218 1 2023-10-01 2024-09-30 12317218 2 2023-10-01 2024-09-30 12317218 core:PlantMachinery 2023-10-01 2024-09-30 12317218 countries:England 2023-10-01 2024-09-30 12317218 bus:FRS102 2023-10-01 2024-09-30 12317218 bus:FilletedAccounts 2023-10-01 2024-09-30 12317218 2024-09-30 12317218 core:WithinOneYear 2024-09-30 12317218 core:AfterOneYear 2024-09-30 12317218 core:ShareCapital 2024-09-30 12317218 core:RetainedEarningsAccumulatedLosses 2024-09-30 12317218 core:PlantMachinery 2024-09-30 12317218 2023-09-30 12317218 core:PlantMachinery 2023-09-30 iso4217:GBP xbrli:pure